The postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
infection (PASC), also known as post‐acute coronavirus disease 19 (COVID‐19) or the long …

Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

COVID-19 may manifest as mild, moderate or severe disease with each grade of severity
having its own features and post-viral implications. With the rising burden of the pandemic, it …

Abstract Introduction COVID-19 long-haulers, also decribed as having “long-COVID” or post-
acute COVID-19 syndrome, represent 10% of COVID-19 patients and remain understudied …

Post-acute sequelae of SARS-CoV-2 (PASC), also known as Post-Covid Syndrome, and
colloquially as Long Covid, has been defined as a constellation of signs and symptoms …

As of February 2023, there have been approximately 759 million confirmed cases of COVID-
19 infections globally1 and some individuals have experienced persistent symptoms, such …

Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …

Intense investigation into the predictors and determinants of post-acute sequelae of SARS-
CoV-2 infection (PASC), including 'long COVID', is underway. Recent studies provide clues …

Since late 2019, the novel coronavirus SARS-CoV-2 has introduced a wide array of health
challenges globally. In addition to a complex acute presentation that can affect multiple …

It is now well recognized that COVID-19 presents with an organ dominant syndromic
disease in which the lungs are mostly the commonest organ being involved. Another benefit …